These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 17619788)

  • 1. An open-label study of an herbal topical medication (QoolSkin) for patients with chronic plaque psoriasis.
    Cohen AD; Shalev R; Yaniv R; Shemer A
    ScientificWorldJournal; 2007 Jul; 7():1063-9. PubMed ID: 17619788
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effectiveness of climatotherapy at the Dead Sea for psoriasis vulgaris: A community-oriented study introducing the 'Beer Sheva Psoriasis Severity Score'.
    Cohen AD; Van-Dijk D; Naggan L; Vardy DA
    J Dermatolog Treat; 2005; 16(5-6):308-13. PubMed ID: 16428150
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Open-label, single-center, safety dose escalation trial of alefacept for the treatment of moderate to severe chronic plaque psoriasis.
    Moul DK; Routhouska SB; Korman NJ
    J Cutan Med Surg; 2007; 11(4):132-6. PubMed ID: 17601420
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy and tolerability of a cosmetically acceptable coal tar solution in the treatment of moderate plaque psoriasis: a controlled comparison with calcipotriene (calcipotriol) cream.
    Alora-Palli MB; Perkins AC; Van Cott A; Kimball AB
    Am J Clin Dermatol; 2010; 11(4):275-83. PubMed ID: 20513160
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oral PSORI-CM01, a Chinese herbal formula, plus topical sequential therapy for moderate-to-severe psoriasis vulgaris: pilot study for a double-blind, randomized, placebo-controlled trial.
    Yao DN; Lu CJ; Wen ZH; Yan YH; Xuan ML; Li XY; Li G; He ZH; Xie XL; Deng JW; Guo XF; Ou AH
    Trials; 2016 Mar; 17(1):140. PubMed ID: 26983642
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy and safety of infliximab vs. methotrexate in patients with moderate-to-severe plaque psoriasis: results of an open-label, active-controlled, randomized trial (RESTORE1).
    Barker J; Hoffmann M; Wozel G; Ortonne JP; Zheng H; van Hoogstraten H; Reich K
    Br J Dermatol; 2011 Nov; 165(5):1109-17. PubMed ID: 21910713
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Factor analysis of the Beer Sheva Psoriasis Severity Score (BPSS).
    Cohen AD; Van-Dijk D; Naggan L; Vardy DA
    Isr Med Assoc J; 2008 Jun; 10(6):419-23. PubMed ID: 18669137
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative evaluation of topical calcipotriol versus coal tar and salicylic acid ointment in chronic plaque psoriasis.
    Singh P; Gupta S; Abidi A; Krishna A
    J Drugs Dermatol; 2013 Aug; 12(8):868-73. PubMed ID: 23986159
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy of Novel Topical Liposomal Formulation of Cyclosporine in Mild to Moderate Stable Plaque Psoriasis: A Randomized Clinical Trial.
    Kumar R; Dogra S; Amarji B; Singh B; Kumar S; Sharma ; Vinay K; Mahajan R; Katare OP
    JAMA Dermatol; 2016 Jul; 152(7):807-15. PubMed ID: 27096709
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tacalcitol ointment for long-term control of chronic plaque psoriasis in dermatological practice.
    Lambert J; Trompke C
    Dermatology; 2002; 204(4):321-4. PubMed ID: 12077538
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy and safety of systemic methotrexate in two fixed doses of 10 mg or 25 mg orally once weekly in adult patients with severe plaque-type psoriasis: a prospective, randomized, double-blind, dose-ranging study.
    Dogra S; Krishna V; Kanwar AJ
    Clin Exp Dermatol; 2012 Oct; 37(7):729-34. PubMed ID: 22830389
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical effectiveness and safety experience with alefacept in the treatment of patients with moderate-to-severe chronic plaque psoriasis in Taiwan: results of an open-label, single-arm, multicentre pilot study.
    Huang PH; Liao YH; Wei CC; Tseng YH; Ho JC; Tsai TF
    J Eur Acad Dermatol Venereol; 2008 Aug; 22(8):923-30. PubMed ID: 18312328
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy of a day-care program in the treatment of psoriasis.
    Zhang J; Adam DN; Stebbing E; Gerbrandt J; Lui H; Shapiro J; Zhou Y
    J Cutan Med Surg; 2008; 12(5):211-6. PubMed ID: 18845089
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term efficacy and safety of infliximab maintenance therapy in patients with plaque-type psoriasis in real-world practice.
    Shear NH; Hartmann M; Toledo-Bahena M; Katsambas A; Connors L; Chang Q; Yao R; Nograles K; Popmihajlov Z;
    Br J Dermatol; 2014 Sep; 171(3):631-41. PubMed ID: 24673357
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term use of topical calcipotriol in chronic plaque psoriasis.
    Ramsay CA; Berth-Jones J; Brundin G; Cunliffe WJ; Dubertret L; van de Kerkhof PC; Menne T; Wegmann E
    Dermatology; 1994; 189(3):260-4. PubMed ID: 7949479
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy and safety of secukinumab in the treatment of moderate-to-severe plaque psoriasis: a randomized, double-blind, placebo-controlled phase II dose-ranging study.
    Papp KA; Langley RG; Sigurgeirsson B; Abe M; Baker DR; Konno P; Haemmerle S; Thurston HJ; Papavassilis C; Richards HB
    Br J Dermatol; 2013 Feb; 168(2):412-21. PubMed ID: 23106107
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Calcipotriol ointment versus cream in psoriasis vulgaris.
    Duweb G; Aldebani S; Elzorghany A; Benghazil M; Alhaddar J
    Int J Clin Pharmacol Res; 2003; 23(2-3):47-51. PubMed ID: 15018018
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of weight reduction on treatment outcomes in obese patients with psoriasis on biologic therapy: a randomized controlled prospective trial.
    Al-Mutairi N; Nour T
    Expert Opin Biol Ther; 2014 Jun; 14(6):749-56. PubMed ID: 24661040
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fumaderm® in daily practice for psoriasis: dosing, efficacy and quality of life.
    Walker F; Adamczyk A; Kellerer C; Belge K; Brück J; Berner T; Merten K; Núnez Gómez N; Neureither M; Röcken M; Ghoreschi K;
    Br J Dermatol; 2014 Nov; 171(5):1197-205. PubMed ID: 24813676
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A randomized study to evaluate the efficacy and safety of adding topical therapy to etanercept in patients with moderate to severe plaque psoriasis.
    Lebwohl MG; Kircik L; Callis Duffin K; Pariser D; Hooper M; Wenkert D; Thompson EH; Yang J; Kricorian G; Koo J
    J Am Acad Dermatol; 2013 Sep; 69(3):385-92. PubMed ID: 23643256
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.